
President Trump is promising $90 payments to help seniors cover Medicare Part B premiums ahead of the Nov. 3 midterm elections.
12:58 PMStat News5 stories from 3 sources
Supporting Articles

President Trump is promising $90 payments to help seniors cover Medicare Part B premiums ahead of the Nov. 3 midterm elections.
12:58 PMStat NewsNew Jersey has reported its first West Nile virus death of the year as virus activity increases in the state, even while national trends have slowed.
11:03 AMGothamist
A small trial found that high-dose vitamin B3 added to standard glioblastoma treatment left 82% of patients progression-free after six months. Researchers suspect niacin may help restore immune activity suppressed by the tumor, but the result requires confirmation in larger studies.
6:09 AMScienceDaily
Summary
President Trump is promising $90 payments to help seniors cover Medicare Part B premiums ahead of the Nov. 3 midterm elections.
The proposal would put direct financial relief for Medicare beneficiaries at the center of the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The plan links seniors’ health-care costs to an election-year fight over benefits, spending, and political influence.
Summary
New Jersey has reported its first West Nile virus death of the year as virus activity increases in the state, even while national trends have slowed.
The key shift is a worsening state-level outbreak despite broader national improvement. The death raises
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
National averages can obscure local outbreaks that require immediate public-health action.

Summary
A small trial found that high-dose vitamin B3 added to standard glioblastoma treatment left 82% of patients progression-free after six months. Researchers suspect niacin may help restore immune activity suppressed by the tumor, but the result requires confirmation in larger studies.
The early signal is promising but too small to change glioblastoma treatment yet. The main
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
An inexpensive, widely available vitamin could expand treatment options for glioblastoma if the result survives rigorous testing.
A curated list of other prominent stories from this day.

Researchers found that 20 minutes of comfortable walking increased the strength, frequency, and duration of bowel sounds within one to two minutes. The effect faded after a few minutes, but it suggests walking can briefly stimulate intestinal movement.
9:58 PMScienceDaily
A UCLA study linked certain gut bacteria and their chemical byproducts with signs of faster brain aging, along with poorer memory, focus, and mood. The findings raise the possibility that gut-related markers could identify brain-aging risk before obvious symptoms appear.
7:28 AMScienceDaily
Summary
Researchers found that 20 minutes of comfortable walking increased the strength, frequency, and duration of bowel sounds within one to two minutes. The effect faded after a few minutes, but it suggests walking can briefly stimulate intestinal movement.
The key finding is the speed of the response, not its duration: gentle walking activated
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A brief walk may offer a simple, immediate way to encourage gut activity without medication.

Summary
A UCLA study linked certain gut bacteria and their chemical byproducts with signs of faster brain aging, along with poorer memory, focus, and mood. The findings raise the possibility that gut-related markers could identify brain-aging risk before obvious symptoms appear.
The decisive finding is an association between gut biology and brain-aging patterns, not proof that
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The gut could become an accessible source of early indicators for brain health, but clinical usefulness and causality remain unproven.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!